Collection of Blood Specimens for Circulating Tumor Cell Analysis

Collection of Blood Specimens for Circulating Tumor Cell Analysis

Objective: To test the sensitivity of a proprietary novel filtration device designed to capture and concentrate circulating tumor cells (CTCs).

Inclusion Criteria:

• Age > 18 years of age
• Written informed consent obtained
• Confirmed diagnosis of stage 2-4 breast, prostate, or colorectal cancer, (OR) no prior history of cancer
• Stage 2-4 treatment naive, metastatic, secondary, and recurrent cancer patients
• Able to undergo blood collection prior to initiation of chemotherapy treatment, (OR) able to provide blood sample if subject is a non-cancer control subject

Exclusion Criteria:

• Patients unable to understand the research protocol and/or provide informed consent.
• Patients with known immunodeficiency, or pregnancy.